Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 12

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 12
---
| Inspire Medical Systems, Inc. |     | 12 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| PROPOSAL NO. 1 |

| Casey M. TanseyAge: 67Independent Director since: 2008                                
 Committee(s):• Organization and Compensation• Quality, Product Supply, and Technology 
 Other Public Boards:• Intersect ENT, Inc. (2006 – 2017)                               
 Education:• B.S. and M.B.A., College of Notre Dame                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |     | Experience:                                                                                                             
 •U.S. Venture Partners, a venture capital investment firm: Managing Partner (since 2014); Managing Member (2005 – 2014) |
|                                                                                       | Qualifications:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 •Industry and Technologyexpertise gained through more than three decades in the medical device industry holding roles at companies such as Epicor Medical, Heartport, Inc., a public company that helped pioneer minimally-invasive cardiac surgery, and Baxter Edward enables Mr. Tansey to bring valuable industry knowledge to our Board. Additionally, his years of experience supporting early-stage medical device companies, including at Epicor Medical, Baxter Edward, and now at U.S. Venture Partners, where his focuses include the development of minimally invasive technologies, helps him contribute deep knowledge of technologies critical to our business. 
 •Chief Executive Officerexperience gained through his service as CEO of Heartport enables him to share perspectives that are relevant to the Board’s oversight responsibilities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 •Financial / Capital Marketsexpertise acquired through extensive experience at his current firm investing in the medical device, biotechnology and healthcare information technology sectors enable him to offer invaluable insights and perspectives regarding financial and capital markets.                                                                                                                                                                                                                                                                                                                                                                                |     |                                                                                                                         |

| Inspire Medical Systems, Inc. |     | 13 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

Corporate Governance Corporate Governance Guidelines Our Board of Directors has adopted Corporate Governance Guidelines. A copy of these Corporate Governance Guidelines can be found in the “Corporate Governance—Governance Documents” section of the “Investors” page of our website located at www.inspiresleep.com, or by writing to our Secretary at our offices at 5500 Wayzata Blvd., Suite 1600, Golden Valley, MN 55416. Among the topics addressed in our Corporate Governance Guidelines are:

| • |     | Board size, independence